Focus on Funding 1/26/07

Featured In: Cancer | Infectious Disease | Health | Pharma

Friday, January 26, 2024

Loading...


GOVERNMENT FUNDING

BioCryst Awarded $102.6M for Flu Research
BioCryst Pharmaceuticals Inc., Birmingham, Ala., has been awarded a $102.6 million, four-year contract from the US Department of Health and Human Services to develop the influenza neuraminidase inhibitor, peramivir, to treat seasonal and life-threatening influenza, including avian flu.
Full Article

GlaxoSmithKline Receives $63M for Pandemic Vaccine Research
GlaxoSmithKline (GSK), Brentford, UK, was awarded a contract from the US Department of Health and Human Services to develop pre-pandemic and pandemic flu vaccines and supports GSK’s ongoing pandemic vaccine research using adjuvant technology in combination with antigens to induce a strong immune response.
Full Article

Novartis Awarded $55M Contract for Antigen Technology
Novartis, Basel, Switzerland, has received a contract from the US Department of Health and Human Services for approximately $55 million to support its efforts to bring the antigen-sparing capabilities of the MF59 adjuvant to the United States for influenza vaccine research.
Full Article

University of Pittsburgh Awarded $13M for COPD Research
The University of Pittsburgh has been awarded an estimated $13 million for a five-year research grant from the National Heart, Lung and Blood Institute to develop novel approaches to increase the understanding of, and improve outcomes for, people with chronic obstructive pulmonary disease (COPD).
Full Article

PRIVATE FUNDING

Cylene Pharmaceuticals Closes $44M in Series C Financing
Cylene Pharmaceuticals Inc., San Diego, Calif., a small molecule oncology drug discovery and development company, announced the closing of a $44 million Series C financing, that will be used to fund human clinical trials for phase II studies of CX-3543 in several different cancer indications and to advance two more products into development.
Full Article

Calypso Pockets $42.2M Financing for Expansion
Calypso Medical Technologies Inc., Seattle, announced that it has closed its Series D private equity financing totaling $42.2 million to support the market launch of the company’s 4D Localization System for use in patients undergoing radiation treatment for prostate cancer.
Full Article

Variation Biotechnologies Secures $35.7M in Series A Financing
Variation Biotechnologies Inc., Gatineau, Canada, a privately held biopharmaceutical company focused on the development of vaccines for infectious diseases using a novel platform technology, has secured $35.7 million in Series A financing.
Full Article

InteKrin Secures $23M in Venture Financing
InteKrin Therapeutics Inc., Palo Alto, Calif., a clinical stage biopharmaceutical company focused developing products for diabetes, metabolism, and obesity, has secured $23 million in venture financing.
Full Article

Sequoia Raises $22M in Series C Financing
Sequoia Pharmaceuticals Inc., Gaithersburg, Md., has raised $22 million in a Series C financing that will be used to further develop its pipeline candidates to treat drug-resistant HIV infections, including an HIV protease inhibitor and a pharmacokinetic enhancer.
Full Article

GRANTS AVAILABLE

Innovative Technologies for Molecular Analysis of Cancer
Agency: National Cancer Institute
Estimated Funding: $200,000
Due Date for Applications: Multiple dates, see Web site
Description: This grant solicits research projects focused on the development of highly innovative cancer-relevant molecular biology technologies, including instrumentation, techniques, and devices.
Full Article

Innovations in Cancer Sample Preparation
Agency: National Institutes of Health
Estimated Funding: $200,000
Due Date for Applications: Multiple dates, see Web site
Description: This grant solicits research projects to develop and significantly enhance or adapt sample preparation methodologies and technologies, the development of assays to assess sample quality, and studies designed to elucidate the criteria by which to judge sample quality.
Full Article

Shared Neurobiology of Fragile X Syndrome and Autism
Agency: National Institutes of Health
Estimated Funding: N/A
Due Date for Applications: Multiple dates, see Web site
Description: This funding opportunity is aimed at characterizing, understanding, and treating etiological and pathophysiological mechanisms common to both Fragile X syndrome and autism (including autism spectrum disorders such as Rett syndrome).
Full Article

Epigenetic Approaches in Cancer Epidemiology
Agency: National Institutes of Health
Estimated Funding: N/A
Due Date for Applications: Multiple dates, see Web site
Description: This grant seeks to stimulate population-based epidemiology research on the roles of DNA methylation markers in cancer. The size and duration of each award will vary.
Full Article

Insulin Signaling and Receptor Cross-Talk
Agency: National Institutes of Health
Estimated Funding: N/A
Due Date for Applications: Multiple dates, see Web site
Description: This grant seeks applications to investigate crosstalk in insulin responses at molecular, cellular, and physiological levels to broaden our understanding of how insulin signals act to regulate coordinated responses between and among insulin responsive tissues.
Full Article

Neurobiology of Migraine
Agency: National Institute of Neurological Disorders and Stroke
Estimated Funding: N/A
Due Date for Applications: Multiple dates, see Web site
Description: This program announcement solicits grant applications from institutions/organizations that intend to perform innovative research to expand current knowledge of neurobiological mechanisms underlying the phases of migraine and the role of neuromodulators such as sex hormones, and genetic influences in migraine pathophysiology.
Full Article

Novel Approaches to Enhance Animal Stem Cell Research
Agency: National Institutes of Health
Estimated Funding: N/A
Due Date for Applications: Multiple dates, see Web site
Description: This grant encourages applications for research to enhance animal stem cells as model biological systems. Innovative approaches to isolate, characterize, and identify toti-potent and multi-potent stem cells from nonhuman biomedical research animal models, as well as to generate reagents and techniques to characterize and separate those stem cells from other cell types, is encouraged.
Full Article


Join the Discussion
Rate Article: Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Research Exchange

Calibration Free Analysis to Measure the Concentration of Active Proteins

Nov 23

An SPR-based method, Calibration Free Concentration Analysis can be used to accurately determine the concentration of active protein in a sample, relating to the specific binding activity of the protein, and without the need for a standard.

Advances in EMCCD Technology: Making Imaging Less Arbitrary

Nov 16

Recent advances in EMCCD technology have solved the problem of non-standardized measurement units by using the photoelectron to standardize imaging experiments.

10 Tips for Successful Sample Concentration and Buffer Exchange

Nov 6

Centrifugal devices with ultrafiltration (UF) membrane can solve common problems researchers face when working with proteins.

Meeting the Challenges of Long-term Time-lapse Imaging

Oct 26

Recent technological developments in the sequence capture of cellular events through a light microscope can be combined to image multiple independent experiments automatically, with many advantages.

The Future of the FDA: Operating in an Electronic World

Oct 12

Acording to an Axendia reseach study, the FDA is currently shifting its organizational and technology infrastructures to facilitate electronic interactions with the companies it regulates.

Tissue Microarrays - Opening up new opportunities in the Therapeutics sector

Oct 12

Tissue Microarray has become a pivotal cog in the wheel for high throughput studies and is an integral part in the validation process for screening results from discovery platforms for expression studies using various approaches.

De Novo Formula Generation with Sub-ppm Confidence

Oct 12

Novel technology embodied in the micrOTOF allows precise measurement of both accurate mass and True Isotopic Pattern (TIP) over a wide dynamic range, allowing for the implementation of an open access system.

PLA 2.0 Software for Analyzing - Parallel-Line and Parallel-Logistic Assays

Oct 12

Biological or potency assays are frequently analyzed with the help of the parallel-line or parallel-logistic (4 or 5 parameter fit) methods. These methods have major advantages over traditional single-point assays.

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Nov 9

Action selection is modulated by external stimuli either directly or via memory retrieval. In a constantly changing environment, animals have evolved attention-like processes to effectively filter the incoming sensory stream. These attention-like processes, in turn, are modulated by memory. The neurobiological nature of how attention, action selection and memory are inter-connected is unknown. We describe here new phenotypes of the memory mutant radish in the fruit fly Drosophila.

Mechanisms of plasticity in simple taxis behaviors in Drosophila

Nov 8

Like the proverbial moth drawn to the candle flame, the fruit fly Drosophila also stereotypically approaches light sources. This positive phototaxis is the archetypal example of hard-wired input-output behaviors.

Live cell imaging of mutant and wild-type GABA-A receptor trafficking using a novel reporter protein

Nov 8

Efficient signaling in the brain requires precise regulation and targeting of cell surface ion-channels. Mutations in these channels associated with inherited diseases can cause improper targeting and reduced surface expression.

ADP-Glo™: An Ideal Approach to Monitor the Activity of Protein Kinases and Beyond

Oct 16

Because of its versatility (alltypesofsubstrates), robustness (Z’>0.8), rapidperformance, and its ease of use, the luminescence based Kinase Glo® assay platform has gained wide acceptance in many drug screening programs for protein kinase inhibitors.

Eukaryotic release factor 1-2 affects Arabidopsis responses to glucose and phytohormones during germination and early seedling development

1 hour ago

Germination and early seedling development are coordinately regulated by glucose and phytohormones such as ABA, GA, and ethylene. However, the molecules that affect plant responses to glucose and phytohormones remain to be fully elucidated. Eukaryotic release factor 1 (eRF1) is...

Blocking the Metabolism of Starch Breakdown Products in Arabidopsis Leaves Triggers Chloroplast Degradation

1 hour ago

In most plants, a large fraction of photo-assimilated carbon is stored in the chloroplasts during the day as starch and remobilized during the subsequent night to support metabolism. Mutations blocking either starch synthesis or starch breakdown in Arabidopsis thaliana reduce...

The hydrophobic patch of ubiquitin is required to protect transactivator-promoter complexes from destabilization by the proteasomal ATPases

1 hour ago

Mono-ubiquitylation of a transactivator is known to promote transcriptional activation of certain transactivator proteins. For the Sacchromyces cerevisiae transactivator, GAL4, attachment of mono-ubiquitin prevents destabilization of the DNA-transactivator complex by the ATPases...

Critical amino acids in human DNA polymerases {eta} and {kappa} involved in erroneous incorporation of oxidized nucleotides

1 hour ago

Oxidized DNA precursors can cause mutagenesis and carcinogenesis when they are incorporated into the genome. Some human Y-family DNA polymerases (Pols) can effectively incorporate 8-oxo-dGTP, an oxidized form of dGTP, into a position opposite a template dA. This inappropriate...

Prokariotic Cell Collection in Denmark

Nov 6

I would like to know about a prokariotic cell collection in Denmark. Is there a cell bank in this country? I need a Lactobacillus strain for a fermentation assay and this information about the bank is very helpful for me.

Request for Entries

Oct 16

Ask the Experts is your chance to get the answers to questions on applications, materials, methods, processes, and technologies. Email you question to bst_web@advantagemedia.com, and the editors of Bioscience Technology will find an appropriate expert to answer it. Watch this space in the future to see the questions your colleagues are posting.

STAY INFORMED: SUBSCRIBE TO

Magazine and E-mail Newsletters

Loading...
E-mail:   

MULTIMEDIA

Video:

Neuroscience Diseases of The Brain and How The Mind Emerges

Neuroscience Diseases of The Brain and How The Mind Emerges

Nov 8

Dennis Choi, director of Emory Universitys Neuroscience Center, is renowned for his groundbreaking research on brain and spinal cord injury.

Podcasts:

Allen Institute for Brain Research

Allen Institute for Brain Research

Oct 14

Discussed in this interview are both the mouse brain project and the human cortex project with an emphasis on the importance of these projects to neuroscience research.